Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report

BACKGROUND: Male breast cancer is a rare event, accounting for approximately 1% of all breast carcinomas. Although men with breast cancer had poorer survival when compared with women, data on prognosis principally derive from retrospective studies and from extrapolation of female breast cancer serie...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballatore, Z., Pistelli, M., Battelli, N., Pagliacci, A., De Lisa, M., Berardi, R., Cascinu, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127048/
https://www.ncbi.nlm.nih.gov/pubmed/27894335
http://dx.doi.org/10.1186/s13104-016-2301-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127048/
https://www.ncbi.nlm.nih.gov/pubmed/27894335
http://dx.doi.org/10.1186/s13104-016-2301-2

Ejemplares similares